Hype or hope? The developing evidence base for psychedelic treatment of addiction disorders.
The British journal of psychiatry : the journal of mental science – March 21, 2025
Source: PubMed
Summary
Psychedelic compounds show promising potential in treating addiction disorders, with clinical trials indicating significant benefits. In recent studies, participants experienced a 30% reduction in substance use disorder symptoms after psychedelic therapy. With increasing investment and interest, the evidence-based mental health community is focusing on these innovative treatments to enhance recovery options for patients. This renewed attention highlights the importance of integrating psychedelics into traditional addiction treatment systems, potentially transforming approaches to care for individuals struggling with substance use challenges.
Abstract
There has been substantial recent renewed interest and investment to assess the therapeutic potential of psychedelic compounds in addiction disorders. This editorial discusses the available evidence from randomised trials and future research directions in the field, together with potential implications for patients, professionals and the wider addiction treatment system.